Keywords: UK, NICE, Amgen, Nplate, PharmaMar, Zeltia, Yondelis, ITP, Ovarian cancer

UK NICE gives final yes for Amgen’s Nplate but no for PharmaMar’s Yondelis

Article | 27 April 2011

Print This

There was mixed news this morning from the UK’s drug rationing body the National Institute for Health and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in